e-learning
resources
Amsterdam 2015
Tuesday, 29.09.2015
Antibiotic resistance in respiratory infections
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The resistome and other mechanisms of antibiotic resistance
Georgina Cox (Hamilton, Canada)
Source:
International Congress 2015 – Antibiotic resistance in respiratory infections
Session:
Antibiotic resistance in respiratory infections
Session type:
Hot topics
Number:
3442
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Georgina Cox (Hamilton, Canada). The resistome and other mechanisms of antibiotic resistance. International Congress 2015 – Antibiotic resistance in respiratory infections
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
Antibiotic resistance in pulmonary infections: mechanisms and epidemiology
Source: Eur Respir Monogr 2017; 75: 21-43
Year: 2017
Impact of antibiotic consumption in the evolution of respiratory
pseudomonas
antibiotic resistance
Source: Eur Respir J 2006; 28: Suppl. 50, 787s
Year: 2006
Shortened multidrug-resistant tuberculosis regimens overcome low-level fluoroquinolone resistance
Source: Eur Respir J, 49 (6) 1700223; 10.1183/13993003.00223-2017
Year: 2017
When and how to identify resistance mechanisms to targeted therapies
Source: New biomarkers, molecules and therapeutic sequences for non small cell lung carcinoma in the era of precision medicine
Year: 2019
The role of increasing bacterial resistance
Source: Annual Congress 2012 - PG17 Clinical failure of treatment of respiratory infections
Year: 2012
Impact of resistance to first-line and injectable drugs on treatment outcomes in MDR-TB
Source: Eur Respir J 2009; 33: 581-585
Year: 2009
Antibiotic management and resistance
Source: Eur Respir Monogr 2018; 81: 312-330
Year: 2018
Characterization of the resistance mechanisms to carbapenems and virulence genes in Pseudomonas aeruginosa strains from children with cystic fibrosis.
Source: Virtual Congress 2021 – Cystic fibrosis in children: various aspects
Year: 2021
Macrolide resistance in
Pseudomonas aeruginosa
: implications for practice
Source: Eur Respir J, 49 (5) 1700689; 10.1183/13993003.00689-2017
Year: 2017
Mechanisms of acquisition of resistance in
Staphylococcus aureus
Source: Annual Congress 2006 - Methicillin resistant
Staphylococcus aureus
(MRSA): a real hospital-based pathogen?
Year: 2006
Epidemiological impact of antibiotic use/misuse in the community
Source: ISSN=1025-448x, ISBN=1-904097-32-4, page=165
Year: 2004
MDR pathogens: definitions, mechanisms and risk factors
Source: International Congress 2015 – PG14 Antibiotic stewardship for respiratory infections
Year: 2015
Prevalence and abundance of selected genes conferring macrolide resistance genes in COPD patients during maintenance treatment with azithromycin
Source: Virtual Congress 2020 – Advances in pharmacological treatment of COPD
Year: 2020
Biological resistance to beta-lactamic antibiotics in patients with respiratory infection in the prediction of efficiency of antibacterial therapy
Source: Virtual Congress 2020 – Lower respiratory tract infections in clinical practice
Year: 2020
Fluoroquinolone resistance in multidrug-resistant
Mycobacterium tuberculosis
independent of fluoroquinolone use
Source: Eur Respir J, 50 (6) 1701633; 10.1183/13993003.01633-2017
Year: 2017
Rapid molecular detection of rifampicin and isoniazid resistance and identification of mutations in resistant genes of multi-drug resistant tuberculosis (MDR-TB) patients
Source: Annual Congress 2011 - Novel strategies for the diagnosis of tuberculosis
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept